T
TriSalus Life Sciences, Inc.
TLSI · NASDAQ · Healthcare · 324M
Closing price
$4.06
-1.69% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-5.1×
Free cash flow yieldFCF yield
-12.3%
Return on equityROE
115.8%
Operating margin
-59.7%
Net debt / EBITDAbalance-sheet strength
-0.4×
Interest coverage
-4.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.